nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—TRPV1—urinary bladder cancer	0.271	0.518	CbGaD
Acetaminophen—NAT2—urinary bladder cancer	0.214	0.409	CbGaD
Acetaminophen—PTGS2—urinary bladder cancer	0.0379	0.0726	CbGaD
Acetaminophen—UGT1A1—Etoposide—urinary bladder cancer	0.0259	0.119	CbGbCtD
Acetaminophen—ABCB1—Mitomycin—urinary bladder cancer	0.025	0.115	CbGbCtD
Acetaminophen—CYP2A6—Fluorouracil—urinary bladder cancer	0.0185	0.0849	CbGbCtD
Acetaminophen—PTGS2—Cisplatin—urinary bladder cancer	0.0159	0.0729	CbGbCtD
Acetaminophen—PTGS2—Etoposide—urinary bladder cancer	0.0156	0.0717	CbGbCtD
Acetaminophen—PTGS1—Etoposide—urinary bladder cancer	0.0132	0.0605	CbGbCtD
Acetaminophen—CYP3A4—Thiotepa—urinary bladder cancer	0.0114	0.0522	CbGbCtD
Acetaminophen—CYP2E1—Etoposide—urinary bladder cancer	0.0102	0.0467	CbGbCtD
Acetaminophen—CYP2C8—Fluorouracil—urinary bladder cancer	0.00911	0.0418	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—urinary bladder cancer	0.00763	0.0351	CbGbCtD
Acetaminophen—CYP2C8—Etoposide—urinary bladder cancer	0.0076	0.0349	CbGbCtD
Acetaminophen—ABCB1—Gemcitabine—urinary bladder cancer	0.00721	0.0331	CbGbCtD
Acetaminophen—CYP1A2—Fluorouracil—urinary bladder cancer	0.00705	0.0324	CbGbCtD
Acetaminophen—NAT2—urine—urinary bladder cancer	0.00662	0.114	CbGeAlD
Acetaminophen—CYP2C9—Fluorouracil—urinary bladder cancer	0.00635	0.0292	CbGbCtD
Acetaminophen—CYP1A2—Etoposide—urinary bladder cancer	0.00589	0.027	CbGbCtD
Acetaminophen—CYP2C9—Cisplatin—urinary bladder cancer	0.0054	0.0248	CbGbCtD
Acetaminophen—ABCB1—Cisplatin—urinary bladder cancer	0.00524	0.0241	CbGbCtD
Acetaminophen—ABCB1—Etoposide—urinary bladder cancer	0.00515	0.0236	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—urinary bladder cancer	0.00351	0.0161	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—urinary bladder cancer	0.0034	0.0156	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—urinary bladder cancer	0.00331	0.0152	CbGbCtD
Acetaminophen—CYP3A4—Etoposide—urinary bladder cancer	0.00308	0.0142	CbGbCtD
Acetaminophen—UGT1A1—urine—urinary bladder cancer	0.00245	0.0423	CbGeAlD
Acetaminophen—UGT1A6—prostate gland—urinary bladder cancer	0.00238	0.0411	CbGeAlD
Acetaminophen—SULT2A1—prostate gland—urinary bladder cancer	0.00221	0.0382	CbGeAlD
Acetaminophen—CYP3A4—Doxorubicin—urinary bladder cancer	0.0021	0.00966	CbGbCtD
Acetaminophen—SULT1E1—prostate gland—urinary bladder cancer	0.00204	0.0352	CbGeAlD
Acetaminophen—CNR1—prostate gland—urinary bladder cancer	0.00191	0.0329	CbGeAlD
Acetaminophen—SULT1A1—prostate gland—urinary bladder cancer	0.00176	0.0303	CbGeAlD
Acetaminophen—UGT1A10—renal system—urinary bladder cancer	0.00174	0.0301	CbGeAlD
Acetaminophen—UGT2B15—prostate gland—urinary bladder cancer	0.00169	0.0292	CbGeAlD
Acetaminophen—NAT2—renal system—urinary bladder cancer	0.00162	0.028	CbGeAlD
Acetaminophen—SULT1A1—seminal vesicle—urinary bladder cancer	0.00148	0.0256	CbGeAlD
Acetaminophen—SULT2A1—female reproductive system—urinary bladder cancer	0.00121	0.0208	CbGeAlD
Acetaminophen—SULT1A1—renal system—urinary bladder cancer	0.0012	0.0207	CbGeAlD
Acetaminophen—TRPV1—epithelium—urinary bladder cancer	0.00114	0.0196	CbGeAlD
Acetaminophen—UGT2B15—urethra—urinary bladder cancer	0.00113	0.0196	CbGeAlD
Acetaminophen—SULT1E1—female reproductive system—urinary bladder cancer	0.00111	0.0192	CbGeAlD
Acetaminophen—CYP1A2—urine—urinary bladder cancer	0.00108	0.0187	CbGeAlD
Acetaminophen—TRPV1—renal system—urinary bladder cancer	0.00105	0.0182	CbGeAlD
Acetaminophen—CYP2C9—urine—urinary bladder cancer	0.00103	0.0178	CbGeAlD
Acetaminophen—SULT1E1—vagina—urinary bladder cancer	0.00101	0.0174	CbGeAlD
Acetaminophen—CYP2E1—urine—urinary bladder cancer	0.000976	0.0169	CbGeAlD
Acetaminophen—SULT1A1—female reproductive system—urinary bladder cancer	0.000958	0.0165	CbGeAlD
Acetaminophen—UGT2B15—female reproductive system—urinary bladder cancer	0.000924	0.016	CbGeAlD
Acetaminophen—UGT1A1—prostate gland—urinary bladder cancer	0.00088	0.0152	CbGeAlD
Acetaminophen—UGT1A9—renal system—urinary bladder cancer	0.000875	0.0151	CbGeAlD
Acetaminophen—SULT1A1—vagina—urinary bladder cancer	0.000867	0.015	CbGeAlD
Acetaminophen—TRPV1—female reproductive system—urinary bladder cancer	0.000844	0.0146	CbGeAlD
Acetaminophen—CYP3A4—urine—urinary bladder cancer	0.000785	0.0136	CbGeAlD
Acetaminophen—CYP2D6—urine—urinary bladder cancer	0.000773	0.0133	CbGeAlD
Acetaminophen—CYP2A6—prostate gland—urinary bladder cancer	0.000741	0.0128	CbGeAlD
Acetaminophen—SULT2A1—lymph node—urinary bladder cancer	0.000706	0.0122	CbGeAlD
Acetaminophen—SULT1E1—lymph node—urinary bladder cancer	0.000651	0.0112	CbGeAlD
Acetaminophen—CYP2A6—seminal vesicle—urinary bladder cancer	0.000627	0.0108	CbGeAlD
Acetaminophen—CNR1—lymph node—urinary bladder cancer	0.000609	0.0105	CbGeAlD
Acetaminophen—UGT1A1—renal system—urinary bladder cancer	0.0006	0.0104	CbGeAlD
Acetaminophen—SULT1A1—lymph node—urinary bladder cancer	0.000561	0.00968	CbGeAlD
Acetaminophen—CYP2A6—vagina—urinary bladder cancer	0.000366	0.00632	CbGeAlD
Acetaminophen—CYP2E1—prostate gland—urinary bladder cancer	0.00035	0.00605	CbGeAlD
Acetaminophen—PTGS1—prostate gland—urinary bladder cancer	0.000338	0.00583	CbGeAlD
Acetaminophen—PTGS2—prostate gland—urinary bladder cancer	0.000323	0.00557	CbGeAlD
Acetaminophen—CYP2E1—seminal vesicle—urinary bladder cancer	0.000296	0.00512	CbGeAlD
Acetaminophen—PTGS1—seminal vesicle—urinary bladder cancer	0.000285	0.00493	CbGeAlD
Acetaminophen—CYP2C8—renal system—urinary bladder cancer	0.000284	0.0049	CbGeAlD
Acetaminophen—CYP1A1—epithelium—urinary bladder cancer	0.000282	0.00488	CbGeAlD
Acetaminophen—PTGS2—seminal vesicle—urinary bladder cancer	0.000273	0.00471	CbGeAlD
Acetaminophen—CYP1A2—renal system—urinary bladder cancer	0.000265	0.00458	CbGeAlD
Acetaminophen—CYP1A1—renal system—urinary bladder cancer	0.000262	0.00452	CbGeAlD
Acetaminophen—CYP1A1—urethra—urinary bladder cancer	0.000257	0.00444	CbGeAlD
Acetaminophen—PTGS1—epithelium—urinary bladder cancer	0.000248	0.00428	CbGeAlD
Acetaminophen—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000239	0.00413	CbGeAlD
Acetaminophen—CYP2E1—renal system—urinary bladder cancer	0.000239	0.00412	CbGeAlD
Acetaminophen—PTGS2—epithelium—urinary bladder cancer	0.000237	0.00409	CbGeAlD
Acetaminophen—CYP2E1—urethra—urinary bladder cancer	0.000235	0.00405	CbGeAlD
Acetaminophen—PTGS1—renal system—urinary bladder cancer	0.00023	0.00397	CbGeAlD
Acetaminophen—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000228	0.00395	CbGeAlD
Acetaminophen—CYP2C8—female reproductive system—urinary bladder cancer	0.000227	0.00392	CbGeAlD
Acetaminophen—PTGS2—renal system—urinary bladder cancer	0.00022	0.0038	CbGeAlD
Acetaminophen—PTGS2—urethra—urinary bladder cancer	0.000216	0.00373	CbGeAlD
Acetaminophen—CYP1A1—female reproductive system—urinary bladder cancer	0.00021	0.00362	CbGeAlD
Acetaminophen—CYP2C8—vagina—urinary bladder cancer	0.000205	0.00355	CbGeAlD
Acetaminophen—CYP2C9—female reproductive system—urinary bladder cancer	0.000202	0.00349	CbGeAlD
Acetaminophen—ABCB1—prostate gland—urinary bladder cancer	0.0002	0.00345	CbGeAlD
Acetaminophen—CYP3A4—renal system—urinary bladder cancer	0.000192	0.00332	CbGeAlD
Acetaminophen—CYP2E1—female reproductive system—urinary bladder cancer	0.000191	0.0033	CbGeAlD
Acetaminophen—CYP1A1—vagina—urinary bladder cancer	0.00019	0.00328	CbGeAlD
Acetaminophen—CYP2D6—renal system—urinary bladder cancer	0.000189	0.00327	CbGeAlD
Acetaminophen—PTGS1—female reproductive system—urinary bladder cancer	0.000184	0.00318	CbGeAlD
Acetaminophen—PTGS2—female reproductive system—urinary bladder cancer	0.000176	0.00304	CbGeAlD
Acetaminophen—ABCB1—seminal vesicle—urinary bladder cancer	0.000169	0.00292	CbGeAlD
Acetaminophen—PTGS1—vagina—urinary bladder cancer	0.000167	0.00288	CbGeAlD
Acetaminophen—PTGS2—vagina—urinary bladder cancer	0.000159	0.00275	CbGeAlD
Acetaminophen—CYP3A4—female reproductive system—urinary bladder cancer	0.000154	0.00266	CbGeAlD
Acetaminophen—CYP2D6—female reproductive system—urinary bladder cancer	0.000151	0.00262	CbGeAlD
Acetaminophen—ABCB1—epithelium—urinary bladder cancer	0.000147	0.00253	CbGeAlD
Acetaminophen—ABCB1—renal system—urinary bladder cancer	0.000136	0.00235	CbGeAlD
Acetaminophen—ABCB1—urethra—urinary bladder cancer	0.000134	0.00231	CbGeAlD
Acetaminophen—CYP1A1—lymph node—urinary bladder cancer	0.000123	0.00212	CbGeAlD
Acetaminophen—ABCB1—female reproductive system—urinary bladder cancer	0.000109	0.00188	CbGeAlD
Acetaminophen—PTGS1—lymph node—urinary bladder cancer	0.000108	0.00186	CbGeAlD
Acetaminophen—PTGS2—lymph node—urinary bladder cancer	0.000103	0.00178	CbGeAlD
Acetaminophen—ABCB1—vagina—urinary bladder cancer	9.85e-05	0.0017	CbGeAlD
Acetaminophen—Body temperature increased—Cisplatin—urinary bladder cancer	7.14e-05	0.000864	CcSEcCtD
Acetaminophen—Fatigue—Etoposide—urinary bladder cancer	7.13e-05	0.000863	CcSEcCtD
Acetaminophen—Constipation—Etoposide—urinary bladder cancer	7.07e-05	0.000856	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—urinary bladder cancer	7.05e-05	0.000854	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—urinary bladder cancer	7.05e-05	0.000854	CcSEcCtD
Acetaminophen—Hypersensitivity—Fluorouracil—urinary bladder cancer	7.01e-05	0.00085	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—urinary bladder cancer	7.01e-05	0.000849	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—urinary bladder cancer	6.97e-05	0.000844	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—urinary bladder cancer	6.97e-05	0.000844	CcSEcCtD
Acetaminophen—Sweating—Epirubicin—urinary bladder cancer	6.97e-05	0.000844	CcSEcCtD
Acetaminophen—Asthenia—Gemcitabine—urinary bladder cancer	6.95e-05	0.000841	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—urinary bladder cancer	6.88e-05	0.000834	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	6.88e-05	0.000834	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Epirubicin—urinary bladder cancer	6.87e-05	0.000832	CcSEcCtD
Acetaminophen—Pruritus—Gemcitabine—urinary bladder cancer	6.85e-05	0.00083	CcSEcCtD
Acetaminophen—Nausea—Thiotepa—urinary bladder cancer	6.84e-05	0.000828	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—urinary bladder cancer	6.83e-05	0.000828	CcSEcCtD
Acetaminophen—Feeling abnormal—Etoposide—urinary bladder cancer	6.81e-05	0.000825	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—urinary bladder cancer	6.8e-05	0.000824	CcSEcCtD
Acetaminophen—Agranulocytosis—Epirubicin—urinary bladder cancer	6.78e-05	0.000821	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Etoposide—urinary bladder cancer	6.76e-05	0.000819	CcSEcCtD
Acetaminophen—Pruritus—Fluorouracil—urinary bladder cancer	6.74e-05	0.000816	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—urinary bladder cancer	6.72e-05	0.000814	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	6.67e-05	0.000807	CcSEcCtD
Acetaminophen—Hypersensitivity—Cisplatin—urinary bladder cancer	6.65e-05	0.000805	CcSEcCtD
Acetaminophen—Diarrhoea—Gemcitabine—urinary bladder cancer	6.63e-05	0.000802	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—urinary bladder cancer	6.59e-05	0.000798	CcSEcCtD
Acetaminophen—Urticaria—Etoposide—urinary bladder cancer	6.57e-05	0.000796	CcSEcCtD
Acetaminophen—Haemoglobin—Epirubicin—urinary bladder cancer	6.56e-05	0.000794	CcSEcCtD
Acetaminophen—Abdominal pain—Etoposide—urinary bladder cancer	6.54e-05	0.000792	CcSEcCtD
Acetaminophen—Body temperature increased—Etoposide—urinary bladder cancer	6.54e-05	0.000792	CcSEcCtD
Acetaminophen—Haemorrhage—Epirubicin—urinary bladder cancer	6.52e-05	0.00079	CcSEcCtD
Acetaminophen—Hepatitis—Epirubicin—urinary bladder cancer	6.52e-05	0.00079	CcSEcCtD
Acetaminophen—Eye disorder—Methotrexate—urinary bladder cancer	6.52e-05	0.000789	CcSEcCtD
Acetaminophen—Diarrhoea—Fluorouracil—urinary bladder cancer	6.51e-05	0.000789	CcSEcCtD
Acetaminophen—Asthenia—Cisplatin—urinary bladder cancer	6.48e-05	0.000784	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—urinary bladder cancer	6.47e-05	0.000784	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—urinary bladder cancer	6.45e-05	0.000781	CcSEcCtD
Acetaminophen—Urinary tract disorder—Epirubicin—urinary bladder cancer	6.44e-05	0.00078	CcSEcCtD
Acetaminophen—Oedema peripheral—Epirubicin—urinary bladder cancer	6.43e-05	0.000778	CcSEcCtD
Acetaminophen—Connective tissue disorder—Epirubicin—urinary bladder cancer	6.41e-05	0.000776	CcSEcCtD
Acetaminophen—Urethral disorder—Epirubicin—urinary bladder cancer	6.4e-05	0.000775	CcSEcCtD
Acetaminophen—ABCB1—lymph node—urinary bladder cancer	6.37e-05	0.0011	CbGeAlD
Acetaminophen—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	6.36e-05	0.00077	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—urinary bladder cancer	6.33e-05	0.000766	CcSEcCtD
Acetaminophen—Immune system disorder—Methotrexate—urinary bladder cancer	6.3e-05	0.000763	CcSEcCtD
Acetaminophen—Dizziness—Fluorouracil—urinary bladder cancer	6.3e-05	0.000763	CcSEcCtD
Acetaminophen—Mediastinal disorder—Methotrexate—urinary bladder cancer	6.28e-05	0.000761	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—urinary bladder cancer	6.28e-05	0.00076	CcSEcCtD
Acetaminophen—Chills—Methotrexate—urinary bladder cancer	6.26e-05	0.000758	CcSEcCtD
Acetaminophen—Diarrhoea—Cisplatin—urinary bladder cancer	6.18e-05	0.000748	CcSEcCtD
Acetaminophen—Erythema multiforme—Epirubicin—urinary bladder cancer	6.17e-05	0.000747	CcSEcCtD
Acetaminophen—Vomiting—Gemcitabine—urinary bladder cancer	6.16e-05	0.000746	CcSEcCtD
Acetaminophen—Mental disorder—Methotrexate—urinary bladder cancer	6.11e-05	0.00074	CcSEcCtD
Acetaminophen—Rash—Gemcitabine—urinary bladder cancer	6.11e-05	0.000739	CcSEcCtD
Acetaminophen—Dermatitis—Gemcitabine—urinary bladder cancer	6.1e-05	0.000739	CcSEcCtD
Acetaminophen—Eye disorder—Epirubicin—urinary bladder cancer	6.1e-05	0.000738	CcSEcCtD
Acetaminophen—Hypersensitivity—Etoposide—urinary bladder cancer	6.09e-05	0.000738	CcSEcCtD
Acetaminophen—Erythema—Methotrexate—urinary bladder cancer	6.07e-05	0.000735	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—urinary bladder cancer	6.07e-05	0.000735	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—urinary bladder cancer	6.07e-05	0.000735	CcSEcCtD
Acetaminophen—Headache—Gemcitabine—urinary bladder cancer	6.07e-05	0.000735	CcSEcCtD
Acetaminophen—Flushing—Epirubicin—urinary bladder cancer	6.06e-05	0.000733	CcSEcCtD
Acetaminophen—Cardiac disorder—Epirubicin—urinary bladder cancer	6.06e-05	0.000733	CcSEcCtD
Acetaminophen—Vomiting—Fluorouracil—urinary bladder cancer	6.05e-05	0.000733	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—urinary bladder cancer	6.04e-05	0.000731	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—urinary bladder cancer	6.04e-05	0.000731	CcSEcCtD
Acetaminophen—Rash—Fluorouracil—urinary bladder cancer	6e-05	0.000727	CcSEcCtD
Acetaminophen—Dermatitis—Fluorouracil—urinary bladder cancer	6e-05	0.000726	CcSEcCtD
Acetaminophen—Headache—Fluorouracil—urinary bladder cancer	5.96e-05	0.000722	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—urinary bladder cancer	5.96e-05	0.000722	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—urinary bladder cancer	5.95e-05	0.00072	CcSEcCtD
Acetaminophen—Asthenia—Etoposide—urinary bladder cancer	5.93e-05	0.000718	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—urinary bladder cancer	5.93e-05	0.000718	CcSEcCtD
Acetaminophen—Angiopathy—Epirubicin—urinary bladder cancer	5.92e-05	0.000717	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—urinary bladder cancer	5.92e-05	0.000717	CcSEcCtD
Acetaminophen—Immune system disorder—Epirubicin—urinary bladder cancer	5.89e-05	0.000714	CcSEcCtD
Acetaminophen—Mediastinal disorder—Epirubicin—urinary bladder cancer	5.88e-05	0.000712	CcSEcCtD
Acetaminophen—Chills—Epirubicin—urinary bladder cancer	5.85e-05	0.000709	CcSEcCtD
Acetaminophen—Pruritus—Etoposide—urinary bladder cancer	5.85e-05	0.000709	CcSEcCtD
Acetaminophen—Nausea—Gemcitabine—urinary bladder cancer	5.75e-05	0.000697	CcSEcCtD
Acetaminophen—Vomiting—Cisplatin—urinary bladder cancer	5.74e-05	0.000695	CcSEcCtD
Acetaminophen—Vision blurred—Methotrexate—urinary bladder cancer	5.72e-05	0.000693	CcSEcCtD
Acetaminophen—Mental disorder—Epirubicin—urinary bladder cancer	5.72e-05	0.000692	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—urinary bladder cancer	5.71e-05	0.000691	CcSEcCtD
Acetaminophen—Rash—Cisplatin—urinary bladder cancer	5.69e-05	0.000689	CcSEcCtD
Acetaminophen—Dermatitis—Cisplatin—urinary bladder cancer	5.69e-05	0.000689	CcSEcCtD
Acetaminophen—Malnutrition—Epirubicin—urinary bladder cancer	5.68e-05	0.000688	CcSEcCtD
Acetaminophen—Erythema—Epirubicin—urinary bladder cancer	5.68e-05	0.000688	CcSEcCtD
Acetaminophen—Diarrhoea—Etoposide—urinary bladder cancer	5.66e-05	0.000685	CcSEcCtD
Acetaminophen—Nausea—Fluorouracil—urinary bladder cancer	5.66e-05	0.000685	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—urinary bladder cancer	5.64e-05	0.000683	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—urinary bladder cancer	5.63e-05	0.000682	CcSEcCtD
Acetaminophen—Anaemia—Methotrexate—urinary bladder cancer	5.61e-05	0.000679	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—urinary bladder cancer	5.6e-05	0.000679	CcSEcCtD
Acetaminophen—Cardiac disorder—Doxorubicin—urinary bladder cancer	5.6e-05	0.000679	CcSEcCtD
Acetaminophen—Tension—Epirubicin—urinary bladder cancer	5.57e-05	0.000675	CcSEcCtD
Acetaminophen—Nervousness—Epirubicin—urinary bladder cancer	5.52e-05	0.000668	CcSEcCtD
Acetaminophen—Angiopathy—Doxorubicin—urinary bladder cancer	5.48e-05	0.000663	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—urinary bladder cancer	5.47e-05	0.000663	CcSEcCtD
Acetaminophen—Dizziness—Etoposide—urinary bladder cancer	5.47e-05	0.000662	CcSEcCtD
Acetaminophen—Muscle spasms—Epirubicin—urinary bladder cancer	5.46e-05	0.000661	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—urinary bladder cancer	5.45e-05	0.00066	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—urinary bladder cancer	5.44e-05	0.000659	CcSEcCtD
Acetaminophen—Leukopenia—Methotrexate—urinary bladder cancer	5.43e-05	0.000658	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—urinary bladder cancer	5.42e-05	0.000656	CcSEcCtD
Acetaminophen—Nausea—Cisplatin—urinary bladder cancer	5.36e-05	0.000649	CcSEcCtD
Acetaminophen—Vision blurred—Epirubicin—urinary bladder cancer	5.35e-05	0.000648	CcSEcCtD
Acetaminophen—Cough—Methotrexate—urinary bladder cancer	5.3e-05	0.000641	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—urinary bladder cancer	5.29e-05	0.00064	CcSEcCtD
Acetaminophen—Ill-defined disorder—Epirubicin—urinary bladder cancer	5.27e-05	0.000638	CcSEcCtD
Acetaminophen—Convulsion—Methotrexate—urinary bladder cancer	5.26e-05	0.000637	CcSEcCtD
Acetaminophen—Vomiting—Etoposide—urinary bladder cancer	5.26e-05	0.000637	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—urinary bladder cancer	5.26e-05	0.000636	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—urinary bladder cancer	5.26e-05	0.000636	CcSEcCtD
Acetaminophen—Anaemia—Epirubicin—urinary bladder cancer	5.25e-05	0.000636	CcSEcCtD
Acetaminophen—Agitation—Epirubicin—urinary bladder cancer	5.22e-05	0.000632	CcSEcCtD
Acetaminophen—Rash—Etoposide—urinary bladder cancer	5.21e-05	0.000631	CcSEcCtD
Acetaminophen—Dermatitis—Etoposide—urinary bladder cancer	5.21e-05	0.000631	CcSEcCtD
Acetaminophen—Headache—Etoposide—urinary bladder cancer	5.18e-05	0.000627	CcSEcCtD
Acetaminophen—Chest pain—Methotrexate—urinary bladder cancer	5.17e-05	0.000626	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—urinary bladder cancer	5.16e-05	0.000625	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	5.13e-05	0.000621	CcSEcCtD
Acetaminophen—Malaise—Epirubicin—urinary bladder cancer	5.12e-05	0.00062	CcSEcCtD
Acetaminophen—Discomfort—Methotrexate—urinary bladder cancer	5.1e-05	0.000618	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—urinary bladder cancer	5.1e-05	0.000618	CcSEcCtD
Acetaminophen—Leukopenia—Epirubicin—urinary bladder cancer	5.08e-05	0.000616	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—urinary bladder cancer	5.05e-05	0.000612	CcSEcCtD
Acetaminophen—Palpitations—Epirubicin—urinary bladder cancer	5.02e-05	0.000608	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—urinary bladder cancer	4.99e-05	0.000605	CcSEcCtD
Acetaminophen—Cough—Epirubicin—urinary bladder cancer	4.96e-05	0.0006	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.95e-05	0.0006	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—urinary bladder cancer	4.95e-05	0.0006	CcSEcCtD
Acetaminophen—Convulsion—Epirubicin—urinary bladder cancer	4.92e-05	0.000596	CcSEcCtD
Acetaminophen—Nausea—Etoposide—urinary bladder cancer	4.91e-05	0.000595	CcSEcCtD
Acetaminophen—Hypertension—Epirubicin—urinary bladder cancer	4.9e-05	0.000594	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.88e-05	0.00059	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—urinary bladder cancer	4.86e-05	0.000588	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—urinary bladder cancer	4.86e-05	0.000588	CcSEcCtD
Acetaminophen—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.85e-05	0.000587	CcSEcCtD
Acetaminophen—Chest pain—Epirubicin—urinary bladder cancer	4.84e-05	0.000586	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—urinary bladder cancer	4.83e-05	0.000585	CcSEcCtD
Acetaminophen—Anxiety—Epirubicin—urinary bladder cancer	4.82e-05	0.000584	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—urinary bladder cancer	4.81e-05	0.000583	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	4.8e-05	0.000582	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—urinary bladder cancer	4.79e-05	0.00058	CcSEcCtD
Acetaminophen—Discomfort—Epirubicin—urinary bladder cancer	4.78e-05	0.000579	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—urinary bladder cancer	4.74e-05	0.000574	CcSEcCtD
Acetaminophen—Dry mouth—Epirubicin—urinary bladder cancer	4.73e-05	0.000573	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—urinary bladder cancer	4.72e-05	0.000572	CcSEcCtD
Acetaminophen—Leukopenia—Doxorubicin—urinary bladder cancer	4.7e-05	0.00057	CcSEcCtD
Acetaminophen—Confusional state—Epirubicin—urinary bladder cancer	4.67e-05	0.000566	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—urinary bladder cancer	4.64e-05	0.000562	CcSEcCtD
Acetaminophen—Oedema—Epirubicin—urinary bladder cancer	4.64e-05	0.000561	CcSEcCtD
Acetaminophen—Anaphylactic shock—Epirubicin—urinary bladder cancer	4.64e-05	0.000561	CcSEcCtD
Acetaminophen—Hypotension—Methotrexate—urinary bladder cancer	4.63e-05	0.000561	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—urinary bladder cancer	4.59e-05	0.000555	CcSEcCtD
Acetaminophen—Shock—Epirubicin—urinary bladder cancer	4.56e-05	0.000552	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—urinary bladder cancer	4.55e-05	0.000551	CcSEcCtD
Acetaminophen—Nervous system disorder—Epirubicin—urinary bladder cancer	4.55e-05	0.000551	CcSEcCtD
Acetaminophen—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.54e-05	0.00055	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—urinary bladder cancer	4.54e-05	0.000549	CcSEcCtD
Acetaminophen—Tachycardia—Epirubicin—urinary bladder cancer	4.52e-05	0.000548	CcSEcCtD
Acetaminophen—Skin disorder—Epirubicin—urinary bladder cancer	4.5e-05	0.000545	CcSEcCtD
Acetaminophen—Hyperhidrosis—Epirubicin—urinary bladder cancer	4.48e-05	0.000543	CcSEcCtD
Acetaminophen—Insomnia—Methotrexate—urinary bladder cancer	4.48e-05	0.000543	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—urinary bladder cancer	4.47e-05	0.000542	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—urinary bladder cancer	4.46e-05	0.00054	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	4.44e-05	0.000538	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—urinary bladder cancer	4.42e-05	0.000535	CcSEcCtD
Acetaminophen—Anorexia—Epirubicin—urinary bladder cancer	4.42e-05	0.000535	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—urinary bladder cancer	4.42e-05	0.000535	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—urinary bladder cancer	4.4e-05	0.000533	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—urinary bladder cancer	4.38e-05	0.00053	CcSEcCtD
Acetaminophen—Dyspepsia—Methotrexate—urinary bladder cancer	4.36e-05	0.000528	CcSEcCtD
Acetaminophen—Hypotension—Epirubicin—urinary bladder cancer	4.33e-05	0.000525	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—urinary bladder cancer	4.32e-05	0.000524	CcSEcCtD
Acetaminophen—Decreased appetite—Methotrexate—urinary bladder cancer	4.31e-05	0.000521	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—urinary bladder cancer	4.29e-05	0.000519	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—urinary bladder cancer	4.29e-05	0.000519	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	4.28e-05	0.000518	CcSEcCtD
Acetaminophen—Fatigue—Methotrexate—urinary bladder cancer	4.27e-05	0.000517	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—urinary bladder cancer	4.22e-05	0.000511	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—urinary bladder cancer	4.21e-05	0.000509	CcSEcCtD
Acetaminophen—Thrombocytopenia—Doxorubicin—urinary bladder cancer	4.2e-05	0.000509	CcSEcCtD
Acetaminophen—Insomnia—Epirubicin—urinary bladder cancer	4.19e-05	0.000508	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—urinary bladder cancer	4.19e-05	0.000507	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—urinary bladder cancer	4.17e-05	0.000505	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—urinary bladder cancer	4.15e-05	0.000502	CcSEcCtD
Acetaminophen—Dyspnoea—Epirubicin—urinary bladder cancer	4.13e-05	0.0005	CcSEcCtD
Acetaminophen—Somnolence—Epirubicin—urinary bladder cancer	4.12e-05	0.000499	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—urinary bladder cancer	4.09e-05	0.000495	CcSEcCtD
Acetaminophen—Feeling abnormal—Methotrexate—urinary bladder cancer	4.08e-05	0.000494	CcSEcCtD
Acetaminophen—Dyspepsia—Epirubicin—urinary bladder cancer	4.08e-05	0.000494	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—urinary bladder cancer	4.05e-05	0.000491	CcSEcCtD
Acetaminophen—Decreased appetite—Epirubicin—urinary bladder cancer	4.03e-05	0.000488	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—urinary bladder cancer	4.01e-05	0.000485	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	4e-05	0.000485	CcSEcCtD
Acetaminophen—Fatigue—Epirubicin—urinary bladder cancer	4e-05	0.000484	CcSEcCtD
Acetaminophen—Constipation—Epirubicin—urinary bladder cancer	3.96e-05	0.00048	CcSEcCtD
Acetaminophen—Urticaria—Methotrexate—urinary bladder cancer	3.93e-05	0.000477	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—urinary bladder cancer	3.92e-05	0.000474	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—urinary bladder cancer	3.92e-05	0.000474	CcSEcCtD
Acetaminophen—Insomnia—Doxorubicin—urinary bladder cancer	3.88e-05	0.00047	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—urinary bladder cancer	3.82e-05	0.000463	CcSEcCtD
Acetaminophen—Feeling abnormal—Epirubicin—urinary bladder cancer	3.82e-05	0.000463	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—urinary bladder cancer	3.81e-05	0.000462	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.79e-05	0.000459	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—urinary bladder cancer	3.78e-05	0.000457	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—urinary bladder cancer	3.73e-05	0.000452	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	3.7e-05	0.000448	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—urinary bladder cancer	3.7e-05	0.000448	CcSEcCtD
Acetaminophen—Urticaria—Epirubicin—urinary bladder cancer	3.68e-05	0.000446	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—urinary bladder cancer	3.67e-05	0.000444	CcSEcCtD
Acetaminophen—Body temperature increased—Epirubicin—urinary bladder cancer	3.66e-05	0.000444	CcSEcCtD
Acetaminophen—Abdominal pain—Epirubicin—urinary bladder cancer	3.66e-05	0.000444	CcSEcCtD
Acetaminophen—Hypersensitivity—Methotrexate—urinary bladder cancer	3.65e-05	0.000442	CcSEcCtD
Acetaminophen—Asthenia—Methotrexate—urinary bladder cancer	3.55e-05	0.00043	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.53e-05	0.000428	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.51e-05	0.000425	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—urinary bladder cancer	3.5e-05	0.000424	CcSEcCtD
Acetaminophen—Hypersensitivity—Epirubicin—urinary bladder cancer	3.42e-05	0.000414	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—urinary bladder cancer	3.41e-05	0.000413	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—urinary bladder cancer	3.39e-05	0.000411	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—urinary bladder cancer	3.39e-05	0.000411	CcSEcCtD
Acetaminophen—Diarrhoea—Methotrexate—urinary bladder cancer	3.39e-05	0.00041	CcSEcCtD
Acetaminophen—Asthenia—Epirubicin—urinary bladder cancer	3.33e-05	0.000403	CcSEcCtD
Acetaminophen—Pruritus—Epirubicin—urinary bladder cancer	3.28e-05	0.000397	CcSEcCtD
Acetaminophen—Dizziness—Methotrexate—urinary bladder cancer	3.28e-05	0.000397	CcSEcCtD
Acetaminophen—Diarrhoea—Epirubicin—urinary bladder cancer	3.17e-05	0.000384	CcSEcCtD
Acetaminophen—Hypersensitivity—Doxorubicin—urinary bladder cancer	3.16e-05	0.000383	CcSEcCtD
Acetaminophen—Vomiting—Methotrexate—urinary bladder cancer	3.15e-05	0.000381	CcSEcCtD
Acetaminophen—Rash—Methotrexate—urinary bladder cancer	3.12e-05	0.000378	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—urinary bladder cancer	3.12e-05	0.000378	CcSEcCtD
Acetaminophen—Headache—Methotrexate—urinary bladder cancer	3.1e-05	0.000376	CcSEcCtD
Acetaminophen—Asthenia—Doxorubicin—urinary bladder cancer	3.08e-05	0.000373	CcSEcCtD
Acetaminophen—Dizziness—Epirubicin—urinary bladder cancer	3.07e-05	0.000371	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—urinary bladder cancer	3.03e-05	0.000367	CcSEcCtD
Acetaminophen—Vomiting—Epirubicin—urinary bladder cancer	2.95e-05	0.000357	CcSEcCtD
Acetaminophen—Nausea—Methotrexate—urinary bladder cancer	2.94e-05	0.000356	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—urinary bladder cancer	2.93e-05	0.000355	CcSEcCtD
Acetaminophen—Rash—Epirubicin—urinary bladder cancer	2.92e-05	0.000354	CcSEcCtD
Acetaminophen—Dermatitis—Epirubicin—urinary bladder cancer	2.92e-05	0.000354	CcSEcCtD
Acetaminophen—Headache—Epirubicin—urinary bladder cancer	2.9e-05	0.000352	CcSEcCtD
Acetaminophen—Dizziness—Doxorubicin—urinary bladder cancer	2.84e-05	0.000343	CcSEcCtD
Acetaminophen—Nausea—Epirubicin—urinary bladder cancer	2.75e-05	0.000333	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—urinary bladder cancer	2.73e-05	0.00033	CcSEcCtD
Acetaminophen—Rash—Doxorubicin—urinary bladder cancer	2.7e-05	0.000327	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—urinary bladder cancer	2.7e-05	0.000327	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—urinary bladder cancer	2.69e-05	0.000325	CcSEcCtD
Acetaminophen—Nausea—Doxorubicin—urinary bladder cancer	2.55e-05	0.000309	CcSEcCtD
Acetaminophen—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.25e-06	3.56e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.22e-06	3.54e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.21e-06	3.53e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—GPX1—urinary bladder cancer	4.2e-06	3.52e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—GPX1—urinary bladder cancer	4.2e-06	3.52e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	4.2e-06	3.52e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.19e-06	3.51e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	4.12e-06	3.46e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	4.12e-06	3.46e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.12e-06	3.45e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.09e-06	3.42e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ENO2—urinary bladder cancer	4.08e-06	3.42e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	4.08e-06	3.42e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NAT2—urinary bladder cancer	4.07e-06	3.41e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.05e-06	3.4e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.04e-06	3.39e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—RRM2—urinary bladder cancer	4.04e-06	3.38e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MYC—urinary bladder cancer	3.97e-06	3.33e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	3.96e-06	3.32e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.95e-06	3.31e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.89e-06	3.26e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GSTP1—urinary bladder cancer	3.89e-06	3.26e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—EGFR—urinary bladder cancer	3.89e-06	3.26e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	3.88e-06	3.25e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	3.88e-06	3.25e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.84e-06	3.22e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.81e-06	3.19e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.77e-06	3.16e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.76e-06	3.16e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	3.74e-06	3.13e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ENO2—urinary bladder cancer	3.74e-06	3.13e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.72e-06	3.12e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—NQO1—urinary bladder cancer	3.7e-06	3.1e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	3.68e-06	3.08e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KRAS—urinary bladder cancer	3.67e-06	3.08e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.63e-06	3.04e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	3.63e-06	3.04e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—TYMS—urinary bladder cancer	3.62e-06	3.03e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.61e-06	3.02e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.6e-06	3.01e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GSTM1—urinary bladder cancer	3.58e-06	3e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—NCOR1—urinary bladder cancer	3.58e-06	3e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.57e-06	2.99e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.56e-06	2.99e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.52e-06	2.95e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—NQO1—urinary bladder cancer	3.49e-06	2.92e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.47e-06	2.91e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.45e-06	2.9e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GPX1—urinary bladder cancer	3.42e-06	2.87e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—TYMS—urinary bladder cancer	3.42e-06	2.87e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NCOR1—urinary bladder cancer	3.39e-06	2.84e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	3.38e-06	2.83e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	3.38e-06	2.83e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ERCC2—urinary bladder cancer	3.36e-06	2.82e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.31e-06	2.78e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—NQO1—urinary bladder cancer	3.29e-06	2.76e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.29e-06	2.75e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—urinary bladder cancer	3.26e-06	2.74e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.26e-06	2.73e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.26e-06	2.73e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.25e-06	2.73e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GPX1—urinary bladder cancer	3.24e-06	2.71e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.19e-06	2.67e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ERCC2—urinary bladder cancer	3.19e-06	2.67e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	3.18e-06	2.66e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—MTHFR—urinary bladder cancer	3.16e-06	2.65e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.16e-06	2.65e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PPARG—urinary bladder cancer	3.14e-06	2.63e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PPARG—urinary bladder cancer	3.14e-06	2.63e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.13e-06	2.63e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HRAS—urinary bladder cancer	3.12e-06	2.62e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTP1—urinary bladder cancer	3.09e-06	2.59e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.07e-06	2.57e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.07e-06	2.57e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.04e-06	2.55e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.04e-06	2.55e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.03e-06	2.54e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	3.02e-06	2.53e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	3.02e-06	2.53e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.01e-06	2.53e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MTHFR—urinary bladder cancer	3e-06	2.51e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.99e-06	2.5e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	2.99e-06	2.5e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TERT—urinary bladder cancer	2.99e-06	2.5e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.98e-06	2.5e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.96e-06	2.48e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.95e-06	2.47e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.92e-06	2.45e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	2.91e-06	2.44e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.91e-06	2.44e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—TYMS—urinary bladder cancer	2.87e-06	2.41e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—NCOR1—urinary bladder cancer	2.84e-06	2.38e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTM1—urinary bladder cancer	2.84e-06	2.38e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.81e-06	2.35e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.78e-06	2.33e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.78e-06	2.33e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	2.74e-06	2.3e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FGFR3—urinary bladder cancer	2.74e-06	2.3e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GPX1—urinary bladder cancer	2.72e-06	2.28e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.7e-06	2.27e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.67e-06	2.24e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.67e-06	2.24e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ERCC2—urinary bladder cancer	2.67e-06	2.24e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.65e-06	2.22e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.63e-06	2.2e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.6e-06	2.18e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.6e-06	2.18e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.59e-06	2.17e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPARG—urinary bladder cancer	2.56e-06	2.15e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.56e-06	2.14e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.55e-06	2.14e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—TYMS—urinary bladder cancer	2.55e-06	2.14e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	2.52e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.51e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.51e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—MTHFR—urinary bladder cancer	2.51e-06	2.1e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.48e-06	2.08e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.47e-06	2.07e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	2.47e-06	2.07e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	2.47e-06	2.07e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CREBBP—urinary bladder cancer	2.46e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.45e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPARG—urinary bladder cancer	2.42e-06	2.03e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GPX1—urinary bladder cancer	2.41e-06	2.02e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.38e-06	1.99e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	2.37e-06	1.99e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.36e-06	1.98e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.34e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CREBBP—urinary bladder cancer	2.33e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	2.33e-06	1.95e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.31e-06	1.94e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	2.23e-06	1.87e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.21e-06	1.85e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.19e-06	1.84e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.17e-06	1.82e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.17e-06	1.82e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTEN—urinary bladder cancer	2.16e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTEN—urinary bladder cancer	2.16e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—RHOA—urinary bladder cancer	2.11e-06	1.77e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.1e-06	1.76e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.08e-06	1.74e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.06e-06	1.73e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—EP300—urinary bladder cancer	2.06e-06	1.72e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—EP300—urinary bladder cancer	2.06e-06	1.72e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.05e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.04e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.04e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPARG—urinary bladder cancer	2.03e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.03e-06	1.7e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—urinary bladder cancer	2.02e-06	1.69e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.01e-06	1.69e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.01e-06	1.69e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.01e-06	1.68e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.01e-06	1.68e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.98e-06	1.66e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.95e-06	1.64e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ERBB2—urinary bladder cancer	1.95e-06	1.64e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.95e-06	1.63e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.93e-06	1.62e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.92e-06	1.61e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.92e-06	1.61e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.91e-06	1.6e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.9e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.89e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.88e-06	1.58e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.88e-06	1.58e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.84e-06	1.54e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.82e-06	1.52e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPARG—urinary bladder cancer	1.81e-06	1.51e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.8e-06	1.51e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.78e-06	1.49e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.78e-06	1.49e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.77e-06	1.49e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.77e-06	1.48e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.76e-06	1.47e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.75e-06	1.47e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	1.73e-06	1.45e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.69e-06	1.42e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—EP300—urinary bladder cancer	1.68e-06	1.41e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.68e-06	1.4e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN1A—urinary bladder cancer	1.67e-06	1.4e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PTEN—urinary bladder cancer	1.67e-06	1.4e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.66e-06	1.39e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.66e-06	1.39e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.66e-06	1.39e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.63e-06	1.36e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.62e-06	1.36e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.61e-06	1.35e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.61e-06	1.35e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.59e-06	1.33e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EP300—urinary bladder cancer	1.59e-06	1.33e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.59e-06	1.33e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—SRC—urinary bladder cancer	1.55e-06	1.3e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.54e-06	1.29e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.51e-06	1.27e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.51e-06	1.26e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.44e-06	1.21e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	1.42e-06	1.19e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.42e-06	1.19e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PTEN—urinary bladder cancer	1.4e-06	1.17e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.39e-06	1.16e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MYC—urinary bladder cancer	1.38e-06	1.16e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.36e-06	1.14e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EGFR—urinary bladder cancer	1.35e-06	1.14e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.35e-06	1.13e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.35e-06	1.13e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—EP300—urinary bladder cancer	1.33e-06	1.12e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.31e-06	1.1e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.31e-06	1.09e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.3e-06	1.09e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.29e-06	1.08e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—urinary bladder cancer	1.28e-06	1.07e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.25e-06	1.05e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.25e-06	1.05e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.24e-06	1.04e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.24e-06	1.04e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTEN—urinary bladder cancer	1.24e-06	1.04e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.19e-06	9.95e-06	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—EP300—urinary bladder cancer	1.18e-06	9.9e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.17e-06	9.77e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.15e-06	9.65e-06	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.14e-06	9.52e-06	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.13e-06	9.51e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.11e-06	9.27e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.1e-06	9.18e-06	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HRAS—urinary bladder cancer	1.09e-06	9.12e-06	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.08e-06	9.08e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.07e-06	8.96e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.06e-06	8.88e-06	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTEN—urinary bladder cancer	9.89e-07	8.29e-06	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—EP300—urinary bladder cancer	9.44e-07	7.91e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTEN—urinary bladder cancer	9.32e-07	7.81e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTEN—urinary bladder cancer	9.24e-07	7.75e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	9.06e-07	7.59e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—EP300—urinary bladder cancer	8.89e-07	7.45e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.89e-07	7.45e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.81e-07	7.39e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.54e-07	7.15e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTEN—urinary bladder cancer	7.9e-07	6.62e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—EP300—urinary bladder cancer	7.53e-07	6.31e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.99e-07	5.86e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.1e-07	5.11e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.81e-07	4.87e-06	CbGpPWpGaD
